Today John Cumbers talks with Jason Kelly, Co-founder and CEO of Ginkgo Bioworks. Together they will discuss synthetic biology’s coming of age” and get Jason’s take on several topics, such as the history of programmable biology, Sam Altman, Ai and the role of AI in biology, and the new congressional commission covering national security and emerging biotechnology.
Check out this week's sponsor: Twist Bioscience
Jason Kelly is a co-founder and the CEO of Ginkgo Bioworks. He obtained his doctorate in Bioengineering from MIT in 2008, where he worked on engineering bacteria to produce biofuels. In 2009, Kelly co-founded Ginkgo Bioworks along with four other co-founders. Under his leadership, Ginkgo has grown to become one of the leading companies in the field of synthetic biology, with a focus on developing custom microbes for a wide range of applications, including pharmaceuticals, agriculture, and industrial chemicals. Jason has been recognized for his contributions to synthetic biology, receiving several awards, including MIT Technology Review's Innovator Under 35 and Forbes' 30 Under 30 in Energy.
Connect with Matt: @jrkelly
Connect with John: @johncumbers